Carisma Therapeutics Inc (NASDAQ:CARM)
| 4.24 Delayed Data As of Sep 29 |  -0.24 / -5.36%Today’s Change | 2.75 Today|||52-Week Range 13.00 | -65.22% Year-to-Date |
Latest CARM News | Press Releases
No recent news for Carisma Therapeutics Inc.
Today’s Trading
| Previous close | 4.48 |
| Today’s open | 4.48 |
| Day’s range | 4.15 - 4.59 |
| Volume | 4,975 |
| Average volume (3 months) | 295,018 |
| Market cap | $170.4M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -5,288.59% |
| Earnings growth (this year) | -32.00% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +50.69% |
| P/E ratio | NM |
| Price/Sales | 3.06 |
| Price/Book | 0.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ORTXOrchard Therapeutics... | -0.05 | -0.71% |
| ZOMZomedica Corp | -0.00 | -0.42% |
| VRCAVerrica Pharmaceutic... | +0.08 | +2.11% |
| GNFTGenfit SA | +0.12 | +3.81% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 6, 2023 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $40.0M |
| Annual profit (last year) | -$19.9M |
| Net profit margin | -49.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Philadelphia, Pennsylvania |
Forecasts
